Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(5.31) per share which missed the analyst consensus estimate of $(4.50) by 18 percent. This is a 2555 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $929.63 thousand which missed the analyst consensus estimate of $950.00 thousand by 2.14 percent. This is a 78.91 percent decrease over sales of $4.41 million the same period last year.
Applied DNA Sciences Q2 EPS $(5.31) Misses $(4.50) Estimate, Sales $929.63K Miss $950.00K Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.